Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXA1125 in NASH with Fibrosis
NCT04880187Phase 2Unknown
- Sponsor
- Axcella
- Start
- May 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of AXA1125 in Nonalcoholic steatohepatitis (NASH), sponsored by Axcella. Status: unknown.
02
Drugs
AXA1125
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04880187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04880187.